Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea
European Heart Journal, 06/14/2012
Shah RV et al. – Among patients with acute dyspnoea, MR–proANP is accurate for diagnosis of ADHF, while both MR–proANP and MR–proADM are independently prognostic to 4 years of the follow–up.



